A focused, one-day intensive on neurotoxin injection — built around live patient sessions, not slides. Covers Botox®, Dysport®, Xeomin®, Jeuveau®, and Daxxify®.
Botulinum toxin injections require more than technical skill; they demand a systematic approach to dosing, anatomy, and patient safety. This workshop guides clinicians through the quantitative and qualitative judgments that separate reliable outcomes from unpredictable results. Participants will examine the variables that influence toxin spread, potency, and clinical effect, and will leave with a framework for consistent decision making in everyday practice.
Understanding dose and dilution arithmetic is the foundation of safe practice. The course reviews how to convert manufacturer-specified units to the volume required for each vial, how to account for differences in unit definition between onabotulinumtoxinA, abobotulinumtoxinA, and incobotulinumtoxinA, and how to adjust concentrations for specific treatment zones. Learners will practice calculating final concentrations that balance efficacy with the risk of diffusion, and will explore scenarios where a lower concentration may be preferable to avoid unwanted muscle weakness.
Accurate facial muscle mapping and depth selection are critical for targeted results. The workshop dissects the anatomy of the glabellar, forehead, and peri-ocular regions, highlighting the danger zones where vascular or nerve injury can occur. Attendees will learn how to identify the safe injection planes for each muscle group and how to modify technique when treating patients with atypical anatomy or prior procedures. Special attention is given to recognizing early signs of ptosis and brow asymmetry, and to implementing corrective strategies such as dose reduction, repositioning, or targeted rescue injections.
Onset and duration expectations shape patient counseling and follow-up planning. The session outlines the typical timeline for visible effect, factors that accelerate or delay onset, and variables that influence how long results persist. Clinicians will review contraindications, including active infection, neuromuscular disorders, and certain medication interactions, and will discuss clear criteria for deferring treatment when risk outweighs benefit. The curriculum also addresses how to assess patient suitability based on facial dynamics, aesthetic goals, and medical history.
Ultimately, the workshop emphasizes judgment over rote protocol. Participants will engage in case-based discussions that challenge them to balance potency, anatomy, and patient expectations while anticipating and managing complications. By the end of the training, clinicians will have a refined decision-making process that can be applied to a wide range of cosmetic and therapeutic indications, supporting safe and effective use of botulinum toxin in their practice.
Pulled live from the MD Education calendar. Click any date to see the venue, agenda, and registration.
Tell us a bit about your goals and we'll match you to the right cohort, share pricing, and walk you through payment plans.
Tell us a bit about you and an MD Education advisor will reach out with pricing, dates, and cohort availability.
How do I calculate the correct dilution for a specific toxin vial?
To calculate dilution, start with the total units supplied in the vial and the desired concentration per injection site. Divide the total units by the volume of diluent you plan to add to obtain units per milliliter. For example, adding 2 mL of preservative-free saline to a 100-unit vial yields a concentration of 50 U/mL. Then determine the volume needed for each injection by dividing the prescribed units by the concentration. Always verify the final volume with a calibrated syringe and document the calculation in the patient record. If you need a lower concentration for a delicate area, increase the diluent volume proportionally, but keep the total units consistent with the treatment plan.
What are the key differences in unit potency among the available botulinum toxins?
The three most common botulinum toxin products use distinct unit definitions, so a numeric dose is not interchangeable across brands. OnabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) have roughly equivalent unit potency, meaning 20 U of each produces a similar clinical effect when injected in comparable muscles. AbobotulinumtoxinA (Dysport) is calibrated differently; clinical studies suggest that approximately 2.5 to 3 U of Dysport corresponds to 1 U of Botox or Xeomin for most facial indications. Because conversion ratios are not exact, clinicians should start with the recommended dose for each product and adjust based on individual response rather than relying on a fixed mathematical conversion.
How can I identify the glabellar and periocular danger zones to avoid complications?
Mapping the glabellar and periocular danger zones begins with a thorough understanding of the underlying vascular and neural structures. In the glabellar region, the supratrochlear and supraorbital nerves run just deep to the skin, and the supratrochlear artery lies medially; injecting too superficially or too medially can cause bruising or nerve irritation. Around the eyes, the marginal mandibular branch of the facial nerve and the dorsal nasal artery are at risk if injections are placed too low or too lateral. Use a fine-gauge needle, maintain a perpendicular angle, and limit the volume per point to stay within the safe plane and reduce diffusion into these structures.
What steps should I take if a patient develops ptosis after injection?
If a patient shows ptosis after a glabellar or forehead injection, the first step is to confirm that the drooping is due to toxin spread rather than an unrelated ocular condition. Assess the degree of eyelid lift and ask the patient about visual changes. A common corrective approach is to inject a small amount of preservative-free saline or a low dose of a different toxin into the levator palpebrae superioris to promote temporary contraction, or to use a topical phenylephrine drop to stimulate the muscle. Reassure the patient that most cases resolve within two to three weeks as the toxin effect wanes.
When is it appropriate to defer botulinum toxin treatment?
Deferring treatment is appropriate when the risk of adverse effects outweighs the anticipated benefit. Situations that warrant postponement include active skin infection at the injection site, recent facial surgery or laser resurfacing, uncontrolled neuromuscular disorders such as myasthenia gravis, and the use of medications that potentiate neuromuscular blockade (e.g., aminoglycoside antibiotics). Pregnancy, breastfeeding, and a history of severe allergic reaction to botulinum toxin or its excipients also merit caution. In these cases, discuss alternative aesthetic options or schedule the injection after the underlying condition has resolved and the patient's medication regimen is stable.
What hands-on practice adds that a video demonstration cannot provide?
Video demonstrations provide visual reference, but they cannot replicate the tactile feedback and three-dimensional awareness required for safe injections. Hands-on practice lets clinicians feel tissue resistance, gauge needle depth, and observe how the toxin spreads in real tissue versus a model. It also offers immediate feedback from an instructor who can correct needle angle, injection volume, and placement in real time. This experiential learning builds muscle memory, improves confidence, and reduces the likelihood of inadvertent placement in danger zones, which are critical skills that cannot be fully mastered through observation alone.
How do I determine if botulinum toxin injection falls within my scope of practice?
Whether botulinum toxin injection falls within your scope of practice depends on the regulations of the licensing board that governs your professional license. Review the board's policy statements, statutes, or practice guidelines that define permissible procedures for your credential. If the guidelines allow aesthetic injections, ensure you meet any additional training or supervision requirements they may impose. When in doubt, contact the board directly or consult with a legal advisor familiar with health-care regulations. Maintaining documentation of your training and competency can also help demonstrate compliance with the applicable scope of practice.
